Skip to main navigation Skip to search Skip to main content

Exploring the utility of anti-tNASP antibodies as a cancer screening biomarker in prostate, pancreatic, and ovarian cancer

Research output: Contribution to conference › Poster

Original languageAmerican English
StatePublished - Aug 13 2022

Disciplines

  • Oncology

Cite this